NCT04000529 2025-09-30
Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies
Novartis
Phase 1 Terminated
Novartis
National Taiwan University Hospital
Cliniques universitaires Saint-Luc- Université Catholique de Louvain